CHMP Recommends Approval of Generic Carmustine for Lymphoma, Brain Tumors
News
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of the generic medication Carmustine Obvius (carmustine) for the treatment of non-Hodgkin’s lymphoma, Hodgkin’s ... Read more